Provided by Tiger Trade Technology Pte. Ltd.

Trump Concept

3,210.92
-34.4824-1.06%
Number of Gainers:11
Number of Losers:19
Number of Flat:1
PE:- -
High:3,244.86
Open:3,244.86
Low:3,177.30
Close:3,245.41
Volume:407.04M
Turnover:43.21B
Market Cap:6.10T
Float Cap:5.39T

Loading ...

Caterpillar Inc Stock (CAT) Opened Down by 3.62% on Oct 7: Drivers Behind the Movement

TradingKey
·
Oct 07

They Paid $50,000 and Waited Nine Years. Will Tesla's Roadster Live up to the Hype?

Dow Jones
·
Oct 07

Rothschild & Co Redburn Adjusts Coinbase Global Price Target to $214 From $198

MT Newswires Live
·
Oct 07

Halozyme Therapeutics Shares up 2% After Court Win Against Merck to Block Subcutaneous Keytruda in Select Markets

THOMSON REUTERS
·
Oct 07

UBS Adjusts Price Target on Tesla to $391 From $385, Keeps Neutral Rating

MT Newswires Live
·
Oct 07

Tesla Stock Is Only for the Unrealistically Optimistic, Says Top Investor

TIPRANKS
·
Oct 07

Morgan Stanley Adjusts Price Target on Merck to $177 From $179

MT Newswires Live
·
Oct 07

Helmerich & Payne Forecasts Strong 4Q Results, Continued Momentum Next Year

Dow Jones
·
Oct 07

Tempus AI announces multi-year collaboration with Moderna, Merck

TIPRANKS
·
Oct 07

Halozyme announces Dutch court of the Hague found Merck infringed patents

TIPRANKS
·
Oct 07

Tempus Expands Multi-Year Collaboration with Moderna, Merck on V940 Melanoma Vaccine Commercialization Support

Reuters
·
Oct 07

Halozyme Therapeutics - Iv Version of Keytruda Remains Available and not Covered by Halozyme's Patent or Court Injunction

THOMSON REUTERS
·
Oct 07

Halozyme Therapeutics - Court Rejects Merck's Arguments That Ep622 Patent is Invalid

THOMSON REUTERS
·
Oct 07

Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda Sc in Multiple European Markets

THOMSON REUTERS
·
Oct 07

Halozyme Therapeutics - Court Orders Msd BV to Stop Keytruda Sc Manufacture and Sale in Eight European Countries

THOMSON REUTERS
·
Oct 07

Halozyme Therapeutics - Injunction Forbids Msd from Facilitating Infringement by Affiliates

THOMSON REUTERS
·
Oct 07

Tempus Announces Multi-Year Collaboration with Moderna and Merck

THOMSON REUTERS
·
Oct 07

Morgan Stanley Adjusts Price Target on Eli Lilly to $1,430 From $1,419

MT Newswires Live
·
Oct 07

Breakingviews-Bankers are Sitting on a $4 Trln Rotten Nest Egg

Reuters
·
Oct 07

Microsoft price target raised to $635 from $528 at Evercore ISI

TIPRANKS
·
Oct 07